NCT05262777 - Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour Deficiencies | Biotech Hunter

Enrollment

211

Participants

Timeline

Start Date

May 2, 2022

Primary Completion Date

January 17, 2023

Study Completion Date

March 5, 2024

Conditions

Cheek WrinklesMidface Contour Deficiencies

Interventions

DEVICE

GP0112

Injectable gel

DEVICE

Restylane Lyft Lidocaine

Injectable gel

Trial Locations (15)

T3E 0B2

Galderma Research Site, Calgary

T5J 3S9

Galderma Research Site, Edmonton

T6G 1C3

Galderma Research Site, Edmonton

V5Z 4E1

Galderma Research Site, Vancouver

V6H 1K9

Galderma Research Site, Vancouver

V6H 4E1

Galderma Research Site, Vancouver

R3M 3Z4

Galderma Research Site, Winnipeg

L6J 7W5

Galderma Research Site, Oakville

L4B 1A5

Galderma Research Site, Richmond Hill

M3H 5Y8

Galderma Research Site, Toronto

M4W 2N4

Galderma Research Site, Toronto

M5R 3N8

Galderma Research Site, Toronto

N8W 5L7

Galderma Research Site, Windsor

L4L 8E2

Galderma Research Site, Woodbridge

H2X 2V1

Galderma Research Site, Montreal